Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2009
10/22/2009CA2700586A1 Clonidine formulations in a biodegradable polymer carrier
10/22/2009CA2700578A1 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009CA2700389A1 Methods and compositions for treating post-operative pain comprising clonidine
10/22/2009CA2700002A1 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
10/21/2009EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009EP2110131A1 Anti-tumor composition comprising tissue-accumulating chitosan gel
10/21/2009EP2109619A2 Modifications of peptide compositions to increase stability and delivery efficiency
10/21/2009EP2109465A2 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same
10/21/2009EP2109464A1 Polymers of aliphatic thioester
10/21/2009EP2109454A1 Glp-1 pharmaceutical compositions
10/21/2009EP2109448A2 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
10/21/2009EP2109443A1 Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium
10/21/2009EP2109442A2 Ophthalmic compositions containing a synergistic combination of three polymers
10/21/2009EP1874797B1 Method of preparing grafted polylysine dendrimers
10/21/2009EP1637131B1 Cataplasm base and cataplasm using the same
10/21/2009EP1512404B1 External preparations for treating dermatitis
10/21/2009EP1509533B1 Polyol-modified silanes as precursors for silica
10/21/2009EP1479300B1 Amino acid powder and process for producing the same
10/21/2009EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1169062B1 Heat stable coated colloidal iron oxides
10/21/2009EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances
10/21/2009EP1109576B1 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
10/21/2009CN101563066A Dispersion of polyamino acids in a continuous lipid phase
10/21/2009CN101560718A Method for preparing functional nano fibrous membrane by multi-component consolute single-step method
10/21/2009CN101560259A Method for preparing multifunctional Tylose by plant fibre
10/21/2009CN101559241A Hyaluronic acid-hydroxyapatite nano composite sphere and preparation method
10/21/2009CN101559231A High shearing production method for film coating agent
10/21/2009CN101559230A Special solvent of lansoprazole lyophilized powder for injection
10/21/2009CN101559229A Inhalative and instillative use of semi-fluorised alkanes as active ingredient carriers in the intrapulmonary area
10/21/2009CN101559228A Pharmaceutical composition for treating chronic stable angina pectoris with hyperlipemia
10/21/2009CN101559225A Meningococcus vaccine
10/21/2009CN101559223A Idemic encephalitis diphtheria-pertussis-tetanus combined vaccine
10/21/2009CN101559219A Preparation for phimosis, andrological inflammation and sexual disorder and production method thereof
10/21/2009CN101559202A Zedoary turmeric oil adhesive membrane for external application and preparation method thereof
10/21/2009CN101559198A Medicament for protecting joints and soft tissues
10/21/2009CN101559116A Stable Chinese medicinal freckle-removing soft capsule and preparation method thereof
10/21/2009CN101559103A Sterilizing and itching-relieving medical composition
10/21/2009CN101559100A Acesodyne capsule for heart and stomach
10/21/2009CN101559074A Coccidiostat-decoquinate dry suspension for livestock and poultry and preparation method thereof
10/21/2009CN101559059A Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof
10/21/2009CN101559056A Oral pharmaceutical composition containing lansoprazole and domperidone
10/21/2009CN101559043A Benzene sulfonic acid levo-amlodipine pill and preparation method thereof
10/21/2009CN101559041A Polypeptide medicament sustained release microsphere or microcapsule preparation with uniform grain size and preparation method thereof
10/21/2009CN101559040A Medicament composition of cefotiam hydrochloride and preparation thereof
10/21/2009CN101559039A Method for producing nattokinase liposome from phytosterol
10/21/2009CN101559038A Solid lipid nanoparticles of finasteride and preparation method thereof
10/21/2009CN101559037A Binary solution type preparation for intravenous injection and intracerebral injection
10/21/2009CN101559036A Conception control gel composition for vagina as well as preparation method and application thereof
10/21/2009CN100552016C Bifidobacterium in treatment of inflammatory disease
10/21/2009CN100551911C Polyphenols compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551910C Styryl compound modified by azo-containing heterocyclic and use thereof
10/21/2009CN100551445C Self assembled precusor liposome containing hard soluble medicine and its preparation method
10/21/2009CN100551444C Stabilization of solid thyroid drug formulations
10/21/2009CN100551443C Nano carbon tube infusion agent preparation method
10/21/2009CN100551441C Compositions comprising neisseria meningitidis sero-group B and C and other antigen
10/21/2009CN100551440C Therapeutic ultrasonic microvesicle for tumour ultrasonic therapy and its preparing method
10/21/2009CN100551439C Long acting injectable insulin composition and methods of making and using thereof
10/21/2009CN100551435C Moistureproof coating method of Xiaojianzhong capsule
10/21/2009CN100551386C Dry coating sustained-release tablet for treating arthritis and preparation process thereof
10/21/2009CN100551384C Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation
10/21/2009CN100551378C Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
10/21/2009CN100551377C Bisphosphonic acid for the treatment and prevention of osteoporosis
10/21/2009CN100551376C Antibiotic slow-release preparation for local use
10/21/2009CN100551369C Sustained release preparation containing cilostazol and its preparation method
10/21/2009CN100551368C Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof
10/21/2009CN100551363C A solid dosage form comprising a fibrate
10/21/2009CN100551358C Method for making particles for use in a pharmaceutical composition
10/21/2009CN100551345C Stable topical drug delivery compositions
10/20/2009US7605236 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia
10/20/2009US7605233 Tumour necrosis factor binding ligands
10/20/2009US7605232 Hydrogels for protein concentration
10/20/2009US7605231 Having organic compound as graft chain and high-molecular weight micelle containing the gelatin derivative; as organic compound, a low molecular weight compound such as succinic acid, ethylenediamine, or high-molecular weight compound such as polyethylene glycol can be used; adhesion preventing membrane
10/20/2009US7605178 Therapeutic compounds
10/20/2009US7605173 Pharmaceutical liquid composition containing pyridone derivative
10/20/2009US7605141 Preserving vitamins subject to oxidative damage by adding a sufficient amount of purified nucleic acid to vitamin such that the rate of oxidative damage of the vitamin is reduced
10/20/2009US7605136 Epothilone - saccharide complex; antiproliferative agents; antitumor agents; antiinflammatory agents; central nervous system disorders; multiple sclerosis; Alzheimer's disease; rheumatic disorders; antiarthritic agents
10/20/2009US7605125 Anticancer agents
10/20/2009US7605124 an ejection liquid for stably ejecting a solution containing at least one kind of insulin ( polyoxyethylene glycol or polyvinyl alcohol modified insulin), citric acid and a surfactant; ejecting the liquid by a thermal inkjet system
10/20/2009US7605121 Oligopeptide lyophilisate, their preparation and use
10/20/2009US7605120 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis
10/20/2009US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product
10/20/2009US7604812 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins
10/20/2009US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic
10/20/2009US7604797 Compositions and methods for treating burns
10/20/2009US7604185 Generation of therapeutic microfoam
10/20/2009CA2531833C Poly-4-hydroxybutyrate matrices for sustained drug delivery
10/20/2009CA2492854C Sustained-release tablet composition of pramipexole
10/20/2009CA2481593C Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
10/20/2009CA2446712C System for osmotic delivery of pharmaceutically active agents
10/20/2009CA2415782C Dermatological composition comprising a multiplicity of particles
10/20/2009CA2413088C Preservative
10/20/2009CA2402267C Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails
10/20/2009CA2393638C Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
10/20/2009CA2389349C Aerosol composition comprising formoterol
10/20/2009CA2376894C Pharmaceutical composition comprising a protein and an ectoine
10/20/2009CA2376226C New formulation
10/20/2009CA2360110C Sustained release salts of pharmaceutically active peptides and their production
10/20/2009CA2354705C Process for producing deoiled phosphatides
10/20/2009CA2339482C Composite hydrogel drug delivery systems